Healthcare provider profile · identity verified

Seth M Turner, MD

Family Practice · GRAND JUNCTION, CO · NPI 1487067591

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	392	103
Lisinopril	Lisinopril	301	77
Levothyroxine Sodium	Levothyroxine Sodium	217	59
Amlodipine Besylate	Amlodipine Besylate	188	55
Gabapentin	Gabapentin	171	45
Hydrochlorothiazide	Hydrochlorothiazide	164	43
Simvastatin	Simvastatin	155	36
Omeprazole	Omeprazole	145	37
Metformin Hcl	Metformin Hcl	134	38
Losartan Potassium	Losartan Potassium	120	37
Tamsulosin Hcl	Tamsulosin Hcl	110	29
Pantoprazole Sodium	Pantoprazole Sodium	106	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	27
Metoprolol Succinate	Metoprolol Succinate	89	25
Rosuvastatin Calcium	Rosuvastatin Calcium	78	31
Albuterol Sulfate Hfa	Albuterol Sulfate	77	29
Zolpidem Tartrate	Zolpidem Tartrate	76	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	15
Sertraline Hcl	Sertraline Hcl	74	18
Allopurinol	Allopurinol	68	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	18
Tramadol Hcl	Tramadol Hcl	66	24
Trazodone Hcl	Trazodone Hcl	59	18
Lorazepam	Lorazepam	57	suppressed
Tizanidine Hcl	Tizanidine Hcl	57	12
Metformin Hcl Er	Metformin Hcl	54	14
Pravastatin Sodium	Pravastatin Sodium	54	16
Oxycodone Hcl	Oxycodone Hcl	52	15
Eliquis	Apixaban	49	16
Alprazolam	Alprazolam	48	17
Lovastatin	Lovastatin	44	suppressed
Alendronate Sodium	Alendronate Sodium	43	13
Furosemide	Furosemide	42	13
Metoprolol Tartrate	Metoprolol Tartrate	42	suppressed
Carvedilol	Carvedilol	41	suppressed
Glipizide	Glipizide	40	14
Lidocaine	Lidocaine	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Potassium Chloride	Potassium Chloride	39	13
Baclofen	Baclofen	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	13
Citalopram Hbr	Citalopram Hydrobromide	37	11
Duloxetine Hcl	Duloxetine Hcl	35	11
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Ozempic	Semaglutide	35	suppressed
Pregabalin	Pregabalin	34	suppressed
Famotidine	Famotidine	33	suppressed
Ezetimibe	Ezetimibe	32	11
Synthroid	Levothyroxine Sodium	31	suppressed
Finasteride	Finasteride	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Prednisone	Prednisone	25	17
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Atenolol	Atenolol	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Cephalexin	Cephalexin	17	13
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error